z-logo
Premium
Genome‐wide detection of oxidized base products in guanine quadruplex (G4) sequences by ChIP‐Seq analysis in hypoxic cells (887.1)
Author(s) -
Pastukh Viktor,
Borchert Glen,
Gillespie Mark
Publication year - 2014
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.28.1_supplement.887.1
Subject(s) - biology , gene , promoter , genome instability , microbiology and biotechnology , hypoxia (environmental) , carcinogenesis , chromatin immunoprecipitation , dna damage , genetics , gene expression , dna , chemistry , oxygen , organic chemistry
Reactive oxygen species (ROS) generated in hypoxic signaling cause a nuclear oxidant stress accompanied by oxidative DNA modifications. Detailed studies on a few genes show that these modifications are prominent in hypoxic responsive promoters (Al‐Mehdi et al, 2012) and G4 sequences in growth regulatory genes (Clark et al., 2012). The G4 damage in hypoxia was interesting because it did not relate to the transcriptional state of the gene, was often localized close to transcription start sites, and because mutations in G4 sequences have been linked to genomic instability and carcinogenesis. To gain more insight into the impact of hypoxia‐generated ROS on genomic integrity, we used ChIP‐Seq analysis to determine if G4 sequences immunoprecipitated by an antibody to the base damage product 8‐oxoguanine were enriched on a genome‐wide scale in pulmonary artery endothelial cells cultured in hypoxia for 3h. We found two notable differences between normoxic and hypoxic cells. First, DNA contigs from hypoxic cells were ≍1/3 the size of those from normoxic cells. Second, the number of 8‐oxoG harboring G4 sequences was enriched by ≍30 fold in hypoxia compared to normoxia. These findings suggest that ROS generated during hypoxic signaling cause widespread base damage in G4 sequences and thereby point to new mechanisms of disease‐causing mutations in this enigmatic gene regulatory region. Grant Funding Source : Supported by the NIH R01HL58234

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here